Christophe Weber
Christophe Weber is President, Chief Executive Officer (CEO) and Representative Director of Takeda Pharmaceutical Company Ltd. He joined the company in April 2014 as Chief Operating Officer, was named President and Representative Director in June 2014, and was subsequently appointed CEO in April 2015. Mr. Weber has focused on globalization, creating a global One Takeda culture and R&D transformation while creating a diverse and inclusive working environment and strengthening the company’s ethical values and corporate governance. Through this transformation, Takeda became one of the leading global biopharmaceutical companies in the world. Prior to joining Takeda, Mr. Weber spent 20 years at GlaxoSmithKline (GSK), where he held senior leadership roles in Europe, Asia and the United States.
Location
Japan
Notable investments
No items found.
Check size range(s)
$500K - $1M
$1M - $3M
$3M - $10M
Rounds their fund invests in
Pre-Seed
Seed
Series A
Series B+
Rounds their fund leads
No items found.
Sectors their fund invests in
Health
Biotech
Geographies their fund invests in
Asia-Pacific
USA
Europe
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
Takeda Digital Ventures
About the Fund
Takeda's investing arm backing digital health companies that improve patient outcomes and the delivery of care.
View Profile
Their Colleagues
No colleagues here yet.
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets
